Back
Results - Announcements
Kerala Ayurveda Ltd consolidated sales down 4.46% on year in Q2FY2026, net profit saw a marginal increase of 9.19%
12-Aug-2026, 06:05
Kerala Ayurveda Ltd share price softened by 0.99% to Rs 155.8 after the company's net profit saw a mild growth of 9.19% to Rs 8.08 crore, while revenue from operations eased by 4.46% to Rs 33.19 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.12 lakh crore, gaining 4.41%. It has improved by 1.16% over last one week and rose by 11.70% in last one month while the market capitalization of Kerala Ayurveda Ltd has slipped by 0.61% and 26.27% in the same period respectively. Profit before tax (PBT) of Kerala Ayurveda Ltd stood at Rs 8.23 crore in Q2 FY26, nosediving by 392.88% year-on-year, and easing 3.13% quarter-on-quarter. EBITDA came in at Rs 4 crore, crashing by 70.06% YoY and plunging by 54.61% sequentially. Total expenses contracted by 10.66% to Rs 38.89 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 7.35 crore, posting a minor increase of 0.27% YoY, while employee benefits expense was at Rs 18.84 crore, registering a marginal contraction of 3.58% YoY. For the TTM ended FY26, revenue from operations improved 16.66% to Rs 120.33 crore, while net profit surged by 2392.86% to Rs 13.96 crore, compared to previous TTM. EBITDA jumped by 1007% to Rs 6.81 crore, and PBT tanked by 1954.55% to Rs 12.24 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 4.83 crore in FY26, as against Rs 0.96 crore in FY25. Kerala Ayurveda Ltd tumbled by 68.99% in last one year, underperforming the benchmark BSE Sensex which has softened by 3.04% during the same period.
Kerala Ayurveda Ltd share price softened by 0.99% to Rs 155.8 after the company's net profit saw a mild growth of 9.19% to Rs 8.08 crore, while revenue from operations eased by 4.46% to Rs 33.19 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.12 lakh crore, gaining 4.41%. It has improved by 1.16% over last one week and rose by 11.70% in last one month while the market capitalization of Kerala Ayurveda Ltd has slipped by 0.61% and 26.27% in the same period respectively. Profit before tax (PBT) of Kerala Ayurveda Ltd stood at Rs 8.23 crore in Q2 FY26, nosediving by 392.88% year-on-year, and easing 3.13% quarter-on-quarter. EBITDA came in at Rs 4 crore, crashing by 70.06% YoY and plunging by 54.61% sequentially. Total expenses contracted by 10.66% to Rs 38.89 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 7.35 crore, posting a minor increase of 0.27% YoY, while employee benefits expense was at Rs 18.84 crore, registering a marginal contraction of 3.58% YoY. For the TTM ended FY26, revenue from operations improved 16.66% to Rs 120.33 crore, while net profit surged by 2392.86% to Rs 13.96 crore, compared to previous TTM. EBITDA jumped by 1007% to Rs 6.81 crore, and PBT tanked by 1954.55% to Rs 12.24 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 4.83 crore in FY26, as against Rs 0.96 crore in FY25. Kerala Ayurveda Ltd tumbled by 68.99% in last one year, underperforming the benchmark BSE Sensex which has softened by 3.04% during the same period.